Anxiety Disorders

Log in for full access to this session if you are registered.

Registration Options

Registrant Resources

Sorry, but you are not an authorized user. Please register for the course at the top of this page.

Faculty Information

Sarah T. Melton, PharmD, BCPP, CGP, FASCP

Learning Objectives

  1. Describe the clinical presentation, signs and symptoms, DSM-IV-TR criteria, and pathophysiology for anxiety disorders.
  2. Explain the use of common rating scales for research, diagnosis and management of anxiety disorders.
  3. Discuss the efficacy of pharmacologic and nonpharmacologic treatment options in the acute and long-term management of anxiety disorders.
  4. Outline the mechanisms of action, pharmacokinetic and pharmacodynamic, pharmacogenetic properties, adverse events, drug interactions, and warnings/precautions for drugs used in anxiety disorders.
  5. Describe treatment guidelines and clinical trials including study design, strengths and weaknesses, and significance of findings for anxiety disorders.
  6. Select an evidence-based drug therapy regimen (drug, dose, schedule and duration of therapy) for stabilizing symptoms and preventing relapse given the clinical presentation of a specific patient.
  7. Outline a plan for monitoring the safety and efficacy of drug therapy, including laboratory tests and managing adverse effects, if appropriate.
  8. Discuss the role of drug therapy in the management of anxiety disorders in special populations (e.g., pregnancy/lactation, children, and elderly).
  9. Identify essential information to discuss during patient counseling about the drug therapy of anxiety disorders.

Course Requirements

Login or register to help identify topics from this page.